Morgan Stanley’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-489,605
Closed -$88M 6854
2017
Q3
$88M Buy
489,605
+345,039
+239% +$62M 0.03% 626
2017
Q2
$15M Buy
144,566
+9,776
+7% +$1.01M ﹤0.01% 1782
2017
Q1
$10.6M Sell
134,790
-7,336
-5% -$576K ﹤0.01% 2139
2016
Q4
$6.37M Buy
142,126
+108,493
+323% +$4.86M ﹤0.01% 2745
2016
Q3
$1.88M Buy
33,633
+14,050
+72% +$785K ﹤0.01% 3545
2016
Q2
$979K Sell
19,583
-3,091
-14% -$155K ﹤0.01% 3985
2016
Q1
$1.04M Buy
22,674
+1,046
+5% +$48K ﹤0.01% 3908
2015
Q4
$1.33M Buy
21,628
+739
+4% +$45.5K ﹤0.01% 3833
2015
Q3
$1.16M Sell
20,889
-12,249
-37% -$682K ﹤0.01% 3992
2015
Q2
$2.02M Sell
33,138
-20,703
-38% -$1.26M ﹤0.01% 3616
2015
Q1
$3.11M Buy
53,841
+27,231
+102% +$1.57M ﹤0.01% 3174
2014
Q4
$1.54M Buy
26,610
+4,313
+19% +$249K ﹤0.01% 3778
2014
Q3
$636K Buy
+22,297
New +$636K ﹤0.01% 4403